AM-6538

AM6538, a long-acting, high-affinity, and pseudo-irreversible cannabinoid antagonist structurally analogous to rimonabant, is a valuable tool for assessing the apparent efficacy of cannabinoid partial and full agonists. It also holds potential for future investigations requiring temporary reductions in cannabinoid receptor availability[1].